← FDA Drug Approvals (Drugs@FDA)

MITOMYCIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2022-11-22

Drug application

FDA Application #
ANDA216648
Application type
Abbreviated New Drug Application (Generic)
Brand name
MITOMYCIN
Generic name
MITOMYCIN
Active ingredients
MITOMYCIN
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
GLAND
Manufacturer
Fresenius Kabi USA, LLC
First approval
2022-11-22

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown